1. Home
  2. RCUS vs KW Comparison

RCUS vs KW Comparison

Compare RCUS & KW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • KW
  • Stock Information
  • Founded
  • RCUS 2015
  • KW 1977
  • Country
  • RCUS United States
  • KW United States
  • Employees
  • RCUS N/A
  • KW N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • KW Real Estate
  • Sector
  • RCUS Health Care
  • KW Finance
  • Exchange
  • RCUS Nasdaq
  • KW Nasdaq
  • Market Cap
  • RCUS 1.4B
  • KW 1.5B
  • IPO Year
  • RCUS 2018
  • KW 1992
  • Fundamental
  • Price
  • RCUS $14.35
  • KW $11.12
  • Analyst Decision
  • RCUS Buy
  • KW Hold
  • Analyst Count
  • RCUS 12
  • KW 1
  • Target Price
  • RCUS $34.50
  • KW $13.00
  • AVG Volume (30 Days)
  • RCUS 835.5K
  • KW 503.0K
  • Earning Date
  • RCUS 11-06-2024
  • KW 11-06-2024
  • Dividend Yield
  • RCUS N/A
  • KW 4.40%
  • EPS Growth
  • RCUS N/A
  • KW N/A
  • EPS
  • RCUS N/A
  • KW N/A
  • Revenue
  • RCUS $263,000,000.00
  • KW $483,200,000.00
  • Revenue This Year
  • RCUS $112.97
  • KW N/A
  • Revenue Next Year
  • RCUS N/A
  • KW N/A
  • P/E Ratio
  • RCUS N/A
  • KW N/A
  • Revenue Growth
  • RCUS 119.17
  • KW N/A
  • 52 Week Low
  • RCUS $13.50
  • KW $7.85
  • 52 Week High
  • RCUS $20.31
  • KW $13.27
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 37.76
  • KW 48.25
  • Support Level
  • RCUS $14.19
  • KW $10.67
  • Resistance Level
  • RCUS $15.01
  • KW $11.81
  • Average True Range (ATR)
  • RCUS 0.98
  • KW 0.37
  • MACD
  • RCUS -0.22
  • KW -0.03
  • Stochastic Oscillator
  • RCUS 7.41
  • KW 23.39

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About KW Kennedy-Wilson Holdings Inc.

Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.

Share on Social Networks: